Mary Tagliaferri's Net Worth
$1.03 Million
Who is Mary Tagliaferri?
Mary Tagliaferri has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include ENZO BIOCHEM INC, BIONOVO INC, RayzeBio, Inc., and Y-mAbs Therapeutics, Inc..
SEC CIK
Mary Tagliaferri's CIK is 0001323304
Past Insider Trading and Trends
2024 was Mary Tagliaferri's most active year for acquiring shares with 5 total transactions. Mary Tagliaferri's most active month to acquire stocks was the month of December. 2006 was Mary Tagliaferri's most active year for disposing of shares, totalling 3 transactions. Mary Tagliaferri's most active month to dispose stocks was the month of May. 2010 saw Mary Tagliaferri paying a total of $9,520.00 for 49,787 shares, this is the most they've acquired in one year. In 2007 Mary Tagliaferri cashed out on 250,000 shares for a total of $400,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENZO BIOCHEM INC (ENZ) Snapshot price: $1.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.06% | 79.36K |
—
|
—
| 312.38K |
Jan 31
| |||
Form 4
| +93.14% | 75.19K |
—
|
—
| 155.92K |
Feb 9
| |||
Form 4
| +106.66% | 41.67K |
—
|
—
| 80.73K |
Jul 12
| |||
Form 4
|
∞
| 39.06K |
—
|
—
| 39.06K |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIONOVO INC No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +0.18% | 17K |
$0.56 | $9,520.00 | 9.57M |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
| 9.61M |
Jul 9
| |||
Form 4
| -29.17% | -25.00K |
—
|
—
| 60.7K |
Jun 12
| |||
Form 4/A
| -0.28% | -27.10K |
$0.45 | -$4,533.00 | 9.61M |
Mar 23 - Jun 2
| |||
Form 4
| -0.10% | -10.00K |
$0.45 | -$4,533.00 | 9.57M |
Jun 2
| |||
Form 4
| -2.54% | -250.00K |
$1.60 | -$400,000.00 | 9.6M |
Jan 29
| |||
Form 4
| -0.30% | -30.00K |
—
|
—
| 9.87M |
Jun 7
| |||
Form 4
| -0.25% | -25.00K |
—
|
—
| 9.87M |
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Y-mAbs Therapeutics, Inc. (YMAB) Snapshot price: $13.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.00% | 3.5K |
—
|
—
| 8.15K |
Jun 11
| |||
Form 4
|
∞
| 4.66K |
—
|
—
| 4.66K |
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||